item management s discussion and analysis of financial condition and results of operations results of operations fiscal year as compared with fiscal year sales of  were higher than fiscal year sales of  the sales increase was caused primarily by the  sales of sanova food antimicrobial to novus international  inc during fiscal  sales to novus were million  representing an up front  one time purchase by novus of alcide s prototype application equipment and inventory at the time that novus entered into a distribution agreement with alcide 
interest income for fiscal was  a increase over fiscal interest income of  the increase is due entirely to an increase of funds available for investment 
cost of goods sold was  in fiscal year  or of net sales as compared to  in fiscal year  which was also of net sales 
during the fiscal year there were no material changes in the unit cost components of cost of goods  nor did alcide change its selling prices during the year  and therefore  on balance  cost of goods as a percentage of sales remained essentially unchanged 
royalty obligations the company has an obligation pursuant to certain royalty and consolidation agreements to pay patent holders  some of whom were early investors in the company  a royalty of of its license revenues and of its net cash sales of products subject to such agreements 
in fiscal  net sales of  were covered by the royalty and consolidation agreements compared to  in fiscal the company anticipates paying a royalty of of the net cash sales of its products to the extent they are subject to royalty payments  which payments will increase the company s costs by such amount 
the company believes that it has the ability to provide for these payments in the selling prices of its products 
on february   the company was named as a defendant in a lawsuit filed in united states district court for the southern district of new york by howard alliger  old hill associates  and other individuals who have rights to receive royalties with respect to certain patents assigned to the company 
the complaint alleges that the company has not paid the required amount of royalties due the plaintiffs pursuant to royalty and consolidation agreements 
the complaint seeks damages for unpaid royalties and unjust enrichment  injunctions  and other relief 
research and development research and development expenses in fiscal year were  as compared to  in fiscal the increase over fiscal was caused primarily by inflationary increases for salaries and laboratory supplies and by the testing required to support usda approval of sanova for poultry processing plants 
selling and administrative expense other selling  general and administrative expenses were  in fiscal  a increase over fiscal expenses of  the difference was primarily due to an increase in marketing and promotion expense and an increase in legal fees due to product litigation  offset by a  reduction in executive bonus expense 
income tax the company s statements of operations for fiscal includes a provision for income taxes of  which is a tax rate of of income before provision for income taxes 
the provision for income taxes in fiscal was  or a tax rate of 
the difference in tax rates is due primarily to a provision for state taxes in fiscal  while no such provision was made in fiscal net income net income for fiscal was  an increase of  or over the previous fiscal year 
the increase was achieved as a result of the net sales increase and interest income increases noted above  offset by an increase in operating expenses and the income tax provision 
liquidity the company s cash  cash equivalents and investments in us government securities totaled  at may   a  increase over the previous fiscal year end 
the increase was generated from operations primarily offset by a  repurchase of alcide common stock 
the company anticipates that income during fiscal will be adequate to sustain the company and that its cash resources will enable it to meet its operating requirements and support its capital needs in the ensuing fiscal year 
accounts receivable the company sells its products to customers and distributors on terms typical of the industry 
sales to us customers are on day terms 
sales to international distributors are on day terms 
during the past three fiscal years alcide offered extended terms up to days to abs global  inc  its largest distributor  in exchange for a finance charge equal to of invoice amounts 
in february   abs resumed normal day payment terms to alcide 
this had the effect of reducing accounts receivable from abs by  at may  as compared with may  leases and capital expenditures the company s office and laboratory space is leased under operating leases from unaffiliated lessors 
during fiscal the company spent  on the purchase of fixed assets 
planned capital expenditures for laboratory and office equipment for fiscal year are expected to be less than  in addition  the company may elect to invest capital to supply sanova food quality systems to poultry processing plants to expand the sale of the company s sanova antimicrobial compound 
investments in sanova equipment are estimated to be  to  per processing plant and as many as plants may be started in fiscal if such capital investments were made in sanova food quality systems  the company would expect to offset a portion of the capital investment cost with increased sales revenue 
fiscal year as compared with the company s net sales in fiscal year were  an increase of from the previous fiscal year s  during the fiscal year  abs global  inc reduced its inventory of alcide products by an estimated  this sales reduction was offset by sales of  to iba  inc  which began distributing alcide udder care products in february   and by a novus international  inc s 
million purchase of alcide poultry antimicrobial inventory and equipment  concurrent with the may  distribution agreement 
interest and nonoperating income for the fiscal year was  an increase of from the prior year s  the increase reflects the impact of higher investable liquid assets and a  payment to alcide by novus on february  to secure negotiating rights for a distribution agreement 
cost of goods sold was  in fiscal year  or of sales  as compared to  in fiscal year  or of sales 
the lower cost of goods as a percentage of sales reflects the impact of the sale to novus 
royalty obligations the company has an obligation pursuant to certain royalty and consolidation agreements to pay patent holders  some of whom were early investors in the company  a royalty of of its license revenues and of its net cash sales of products subject to such agreements 
in fiscal  net sales of  were covered by the royalty and consolidation agreements 
research and development research and development expenses in fiscal year were  as compared to  in fiscal year  an increase of 
the increase resulted primarily from fees paid to third parties for clinical testing and outside laboratory testing related to the company s new product development program and expenses related to commercial plant testing of sanova  the company s new poultry processing antimicrobial 
all research and development expenditures were funded by the company in both fiscal years and selling and administrative expense selling and administrative expenses were  in fiscal year  as compared with  in fiscal year  a decrease of 
income taxes the company had available carry forward losses aggregating approximately  at may  and which expire during the years to at the present pace of operations  it is likely that the carry forward losses will be exhausted in fy net income net income for fiscal was  an increase of  or over the previous fiscal year 
the increase was achieved as a result of the net sales increase and interest and non operating income increases noted above  offset by cost of goods and expense increases 
leases and capital expenditures the company s office and laboratory space is leased under operating leases from unaffiliated lessors 
during fiscal  the company spent  on purchases of fixed assets 
planned capital expenditures for fiscal year are expected to be less than  
